Developer of the next-generation proton beam therapy to treat cancer and improve the quality of life of patients
Advanced Oncotherapy plc is dedicated to advancing cancer treatment through innovative proton beam therapy solutions. Focused on the development of the next-generation proton beam therapy, Advanced Oncotherapy plc aims to significantly improve the quality of life for patients worldwide. The company is committed to providing cost-effective and accessible cancer treatment options.
With its primary address at Ground floor 143 Harley street, London, W1G 6BH, GB, Advanced Oncotherapy plc is strategically positioned to serve a global market. Additional locations include Route du Nant-d'Avril 150, Regus The Hive, Meyrin, Geneva 1217, CH; 311 Montgomery Street, Suite 1A, Syracuse, New York 13202, US; Stationsplein 45, Unit A4.004, Rotterdam, NL; and Daresbury Laboratory Keckwick Lane, Warrington, WA4 4AD, GB, enhancing its reach and operational capabilities. Advanced Oncotherapy plc continues to push the boundaries of medical technology to deliver exceptional patient care.
Advanced Oncotherapy plc is poised for continued growth and success in the medical device industry. The company’s ongoing commitment to innovation and accessibility ensures that Advanced Oncotherapy plc remains at the forefront of cancer treatment solutions. We invite the management team to create a customized and exclusive company showcase and product listing on our platform to further highlight Advanced Oncotherapy plc's capabilities and achievements.
Other organizations in the same industry
This company is also known as